|
|
 |
BIO-IMMUNE THERAPY
Bio-immune therapy is not meant as a replacement for conventional
treatment, but rather as an extension of the patient’s possibilities for
achieving a good result. It encompasses the following anti-tumor
strategies:
 |
Immunotherapy:
the immune response is strengthened |
|
|
Apoptosis induction:
programmed cell destruction is induced |
|
|
Anti-angiogenesis:
blood vessel growth to the tumor is closed down |
|
|
Redifferentiation:
the cancer cell’s DNA is transformed |
Treatment Program
Treatment will normally start with a so-called:
| 1) |
Immune profile:
a blood sample is sent to a medical laboratory in Germany, from
which there is obtained a written report. The report describes the
immune system’s level of function and answers the question ”Are
there signs of anti-tumoral activation on the part of the patient’s
immune system against the cancer?” During the 2. consultation
immunotherapy is discussed in relation to the patient’s test
result.
|
The course of treatment is put together
on the basis of the following guidelines:
|
| 2) |
Basic oncological
therapy (diet-supplement program): The anti-cancer diet
is in acid-base balance and easily digestible. Supplement therapy
involves therapeutic concentrations of natural bio-response
modifiers (BRMs) in order to increase the level of immune
function, apoptosis, anti-angiogenesis and redifferentiation.
|
| 3) |
Intravenous Vitamin
C (IV-C): Clinical studies have shown that Vitamin C is
cytotoxic for cancer cells, when it is used in very high
concentrations, which must be given intravenously. Vitamin C
concentrates in cancer cells. Hydrogen peroxide is produced, which
the cancer cell cannot metabolize. Apoptosis induction is triggered,
which results in cell destruction. In addition to its cytotoxic
effect, IV-C is able to mobilize the immune system, improve the
patient’s sense of well-being as well as enhancing the therapeutic
effect of chemotherapy and radiation while at the same time
protecting against the toxic side effects of chemo og radiation.
Vitamin C is given directly into a vein as a 90 gram drip over 3
hours, 1-2 times a week.
|
| 4) |
Immunotherapy:
The immune profile serves as a guide with regards the most
appropriate form of immune therapy. Misteltoe injections are often
called for with signs of deficient activation by killer cells and T
lymphocytes. Other forms of immune therapy are thymus peptides,
proteolytic enzymes, MGN-3 (arabinoxylane) and Factor AF2.
|
| 5) |
Anti-angiogenesis:
Angiogenesis, the ability of cancer cells to form their own network
of blood vessels for nutrition and growth, has been shown to be an
important step in the progression of tumors. Anti-angiogenesis
inhibits the growth of blood vessels to the tumor and hereby is able
to destroy cancer cells. Examples of anti-angiogenic agents are
cartilage extract (BTC), misteltoe, green tea extract and
vascustatin.
|
| 6) |
Redifferentiation:
Normalization of gene transcription in tumor cells has been
demonstrated with enzyme therapy, Vitamin A, Vitamin D3 and DHA.
|
Links
High-Dose IV Vitamin C Selectively Kills Cancer Cells
http://www.tidslerne.dk
http://www.cancerhelp.org.uk
http://www.vitamincfoundation.org/
http://www.orthomed.com/
http://www.garynull.com/documents/vitaminc.htm
http://www.cforyourself.com/
|
